Bayer Intellectual Property Gmbh

Bayer Animal Health Gmbh

Bayer Pharma Aktiengesellschaft

Bayer Aktiengesellschaft

Bayer Schering Pharma Ag

Bayer Healthcare Aktiengesellschaft

Other

Bayer Cropscience Ag

Bayer Aktiengeselischaft

Bayal Animal Health Gmbh

Elanco Animal Health Gmbh

Walter Hübsch

Johannes-Peter Stasch

Alexandros Vakalopoulos

Frank Wunder

Hans-Georg Schwarz

Dieter Lang

Nils Griebenow

Ulrich Görgens

Ulrich Rosentreter

Niels Lindner

Johannes Köbberling

Markus Follmann

Peter Nell

Thomas Krahn

Klaus Dembowsky

Michael Hahn

Andrea Vaupel

Joerg Keldenich

Adeline Köhler

Karl-Heinz Schlemmer

Katja Zimmermann

Gorden Redlich

Hanna Tinel

Daniel Meibom

Eva-Maria Becker

Ulf Bömer

Werner Hallenbach

Adrian Tersteegen

Klemens Lustig

Jörg Keldenich

Joachim Mittendorf

Martina Delbeck

Reiner Fischer

Thomas Bretschneider

Andreas Knorr

Elisabeth Perzborn

Volkhart Min-Jian Li

Bernd Alig

Kerstin Henninger

Friederike Stoll

Andreas Turberg

Kerstin Ilg

Olga Malsam

Herbert Gayer

Joachim Schuhmacher

Peter Kolkhof

Robert Velten

Lars Bärfacker

Uwe Stelzer

Thomas Simon Ilg

Wei Zhuang

Daniel Kulke

Thomas Krämer

Barbara Albrecht-Küpper

Nicole Diedrichs

Claudia Böhm

Claudia Welz

Kirsten Börngen

Maike Hink

Dirk Brohm

Mario Lobell

Mitsuyuki Shimada

Klaus Raming

Ildiko Terebesi

Frank Süssmeier

Marie-Pierre Collin

Sylvia Grünewald

René Martin

Julia Johanna Hahn

Marcus Bauser

Gunter Karig

Anne Decor

Michael Maue

Frank Süβmeier

Iring Heisler

Rolf Henning

Mélanie Héroult

Raimund Kast

Hartmut Schirok

Joachim Telser

Haruka Shimizu

Michael Härter

Ulrich Ebbinghaus-Kintscher

Klaus Münter

Jens-Kerim Ergüden

Holger Paulsen

Eva Maria Becker-Pelster

Sebastian Horstmann

Barbara Albrecht

Martin Adamczewski

Holger Weintritt

Niels Böhnke

Tobias Harschneck

Sabine Arndt

Verena Vöhringer

Joachim Hütter

Arnel B Concepcion

Eva-Maria Becker-Pelster

Verena Voehringer

Melanie Heroult

The present invention covers new quinoline compounds of general formula (I), in which A, R, R, R, R, R, R, and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients. 

Quinoline derivatives

The present invention covers new quinoline compounds of general formula (I): in which A, R, R, R, R, R, R, and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients.

Anthelmintic quinoline-3-carboxamide derivatives

The present invention covers azaquinoline compounds of general formula (I), with A being (A1) or (A2), and in which T, R, R, R, R, R, Rand Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients. 

Azaquinoline derivatives

The present invention covers quinoline compounds of general formula (I), in which A, R, R, R, R, R, R, and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients. 

Quinoline derivatives for treating infections with helminths

The present invention covers bicyclic pyrazole compounds of general formula (I): in which G, A, R, R, R, and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients. 

Bicyclic pyrazole derivatives

The present invention covers new quinoline compounds of general formula (I) in which A, R, R, R, R, R, R, and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients. 

The present invention covers Pyrazolopyrimidine compounds of general formula (I), in which n, o, X, Y, R, Q, R, R, Rand Rare as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients. 

Pyrazolopyrimidine derivatives

The present application relates to novel 5-amino-5,6,7,8-tetrahydroquinoline-2-carboxylic acids, to processes for their preparation, to their use for the treatment and/or prevention of diseases, and to their use for producing medicaments for the treatment and/or prevention of diseases, especially for the treatment and/or prevention of cardiovascular and cardiopulmonary disorders.

5-aminotetrahydroquinoline-2-carboxylic acids and their use

The invention relates inter alia to halogen-substituted compounds of the general formula (I) in which the substituents A, R-Rand Z-Zhave the meanings given in the description. Also described are processes for preparing the compounds of the formula (I) and possible intermediates for the preparation of these compounds. The compounds according to the invention are particularly suitable for controlling insects, arachnids and nematodes in agriculture and ectoparasites in veterinary medicine.

Halogen-substituted compounds

The invention relates inter alia to halogen-substituted compounds of the general formula (II) in which the radicals A-A, T, n, W, Q, Rand Z-Zhave the meanings given in the description. Also described are processes for preparing the compounds of the formula (II). The compounds according to the invention are particularly suitable for controlling insects, arachnids and nematodes in agriculture and ectoparasites in veterinary medicine.

This invention relates to novel substituted 5-(1-benzothiophen-2-yl)pyrrolo[2,1-fJ[1,2,4]triazin-4-amine derivatives having protein tyrosine kinase inhibitory activities, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for treating proliferative disorders, in particular cancer and tumor diseases. 

Substituted benzothienyl-pyrrolotriazines and uses thereof in the treatment cancer

The present application relates to novel substituted fused pyrimidines and triazines, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.

Substituted annulated triazines and use thereof

The present application relates to novel substituted azabicycles, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.

Substituted azabicycles and use thereof

This invention relates to novel substituted 5-(1-benzothiophen-2-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives having protein tyrosine kinase inhibitory activities, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for treating proliferative disorders, in particular cancer and tumor diseases.

Substituted benzothienyl-pyrrolotriazines and uses thereof

Growing community of inventors

Wuppertal, Germany

Walter Hübsch